[HTML][HTML] Hashimoto's Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas

PP Issa, M Omar, Y Buti, CP Issa, B Chabot… - Biomedicines, 2022 - mdpi.com
Hashimoto's thyroiditis (HT)(autoimmune thyroiditis) is a clinicopathological entity
associated with chronic lymphocytic infiltration resulting in hypothyroidism. HT is a double …

[HTML][HTML] Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience

F Cappellacci, GL Canu, ML Lai, E Lori… - Frontiers in …, 2022 - frontiersin.org
Hashimoto's thyroiditis is the most common cause of hypothyroidism in the iodine-sufficient
areas of the world. Differentiated thyroid cancer is the most common thyroid cancer subtype …

[HTML][HTML] Hashimoto Thyroiditis and Mortality in Patients with Differentiated Thyroid Cancer: The National Epidemiologic Survey of Thyroid Cancer in Korea and Meta …

I Yang, JM Yu, HS Chung, YJ Kim, YK Roh… - Endocrinology and …, 2024 - ncbi.nlm.nih.gov
Background Many studies have shown that Hashimoto's thyroiditis (HT) acts as a protective
factor in differentiated thyroid cancer (DTC), but little is known about its effects on mortality …

Multi‐UniFocality (MUF), in contrast to multifocality, in thyroid lesions: Relation to lymphocytic thyroiditis

MD Aydemirli, H Morreau - Pathology International, 2024 - Wiley Online Library
Whereas multifocality typically concerns papillary thyroid carcinoma (PTC) without
specification of intrathyroidal metastatic or independent nature of tumor foci, the designation …

[HTML][HTML] Hashimoto's thyroiditis: A protective factor against recurrence in BRAF-wild type differentiated thyroid carcinoma

PP Issa, M Omar, Y Buti, M Aboueisha, R Munshi… - Cancers, 2023 - mdpi.com
Simple Summary Hashimoto's thyroiditis and BRAF-mutation are protective and risk factors
for thyroid cancer aggressiveness, respectively. We assessed the influence of Hashimoto's …

Effect and Interactions of BRAF on Lymph Node Metastasis in Papillary Thyroid Carcinoma With Hashimoto Thyroiditis

P Li, Y Liu, T Wei, X Wang, J Zhu, R Yang… - The Journal of …, 2024 - academic.oup.com
Context The role of B-Raf proto-oncogene (BRAF) in papillary thyroid carcinoma (PTC) with
Hashimoto thyroiditis (HT) is unknown. Objective We aimed to explore risk factors affecting …

[HTML][HTML] Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence

HR Won, MG Kim, MS Kim, JW Chang… - European Thyroid …, 2023 - etj.bioscientifica.com
Objective: Active surveillance (AS) has been suggested as a management option for low-risk
papillary thyroid microcarcinoma (PTMC). However, the currently proposed selection criteria …

[HTML][HTML] Uni-and Multivariate Analyses of Cancer Risk in Cytologically Indeterminate Thyroid Nodules: A Single-Center Experience

E Battistella, M Mirabella, L Pomba, R Toniato… - Cancers, 2024 - mdpi.com
Simple Summary Almost 30% of thyroid nodules are cytologically indeterminate (TIR3A/3B)
and the risk of malignancy reported in the literature for TIR3A thyroid nodules ranges from …

[HTML][HTML] Sexual disparity and the risk of second primary thyroid cancer: a paradox

M Hussein, L Mueller, PP Issa, M Haidari, L Trinh… - Gland …, 2023 - ncbi.nlm.nih.gov
Background Despite extensive research on sex differences in primary thyroid cancer, there
is a lack of data on the role of sex in the risk of developing second primary thyroid cancer …

甲状腺乳头状癌合并桥本甲状腺炎的临床特点.

孙康, 汪晓明, 王建国 - Journal of Practical Medicine …, 2023 - search.ebscohost.com
目的甲状腺乳头状癌(PTC) 和桥本甲状腺炎(HT) 的发病率均呈上升趋势, 本文着重分析PTC
合并HT 时的临床病理特点, 进一步探讨二者之间的关系. 方法回顾性分析2016 年1 月至2022 …